Federal probe finds problems with chelation study

Jul 02, 2009 By MARILYNN MARCHIONE , AP Medical Writer

(AP) -- A federal investigation has found problems with a controversial study of an alternative medicine treatment for heart attack victims.

A report from the U.S. Office for Human Research Protections says people in the study were not told enough about the potential dangers of the treatment, called chelation ("kee-LAY'shun"). The report says some doctors involved in the study have been disciplined by state medical boards, and at least three are convicted felons.

The government is letting the study go on while the probe continues.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Medical charity accuses US of pushing India to ease patent rules

add to favorites email to friend print save as pdf

Related Stories

Which treatment works best? Top study needs listed

Jun 30, 2009

(AP) -- The government is about to start a huge research effort to prove which are the best treatments for scores of ailments. Irregular heartbeat, prostate cancer, back pain and hearing loss lead the list of medical problems ...

Swine flu cases up to 7, probe expanding

Apr 23, 2009

(AP) -- Health officials say a unique type of swine flu has now been diagnosed in seven people in California and Texas, up from the two reported earlier this week. The five new cases in the two states have all recovered, ...

US swine flu victims had chronic health problems

May 07, 2009

(AP) -- Health officials have released details about the chronic health problems suffered by the two people who died from swine flu in the United States. The Mexican toddler who died in Texas suffered from ...

Mexico City closes museums to stop flu outbreak

Apr 24, 2009

(AP) -- Mexico's federal government has closed museums, libraries, and state-run theaters as well as schools in its overcrowded capital to stop a swine flu outbreak authorities say may have killed as many ...

Recommended for you

Ebola vaccine not before late 2016: GSK researcher

Oct 17, 2014

An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the "primary answer" to the current outbreak, a company researcher ...

Chimerix gets FDA OK to test drug for Ebola

Oct 17, 2014

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Esbriet, ofev approved to treat deadly lung disease

Oct 16, 2014

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).

FDA weighs removing bolded warning from Chantix

Oct 14, 2014

(AP)—The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not ...

Drug-coated balloon catheter approved

Oct 13, 2014

(HealthDay)—The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been approved by the U.S. Food and Drug Administration.

User comments : 4

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
2 / 5 (4) Jul 02, 2009
What study? What are the details? Who is sponsoring it? What are protocols? Will/have they be(en) changed at the last minute to make the study fail, as in past "studies"?

This is an empty article.
E_L_Earnhardt
1 / 5 (1) Jul 02, 2009
CHELATION is a useful process to remove certain chemicals in the blood stream. I doubt it has any use in cellure treatment and could be dangerous! I agree with "deatopmg"!
hrfJC
1.8 / 5 (5) Jul 03, 2009
If this study design is indeed as flawed as described and conducted by convicted medical villains, why is it allowed to continue? Or is this PR merely an anticipated FDA verdict of "ineffective or dangerous" in order to write off chelation once and for all as a lower cost alternative to highly profitable FDA approved therapies that are often more prone to adverse effects.
ToddC
5 / 5 (1) Jul 03, 2009
What a miserable piece of "reporting" on Physorg - didn't anyone review this article? Here is the link to the blog entry by the writer: http://www.newsvi...on-study